InsiderSource
DERM

Journey Medical Corp

SEC CIK 1867066
$6.27 −26.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
31
Most recent
Advertisement

At a glance

Insiders at DERM have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Maraoui Claude sold $246.8K of DERM, trimming their stake 2%.

Most active filer: Maraoui Claude, with 13 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for DERM, newest first
View on SEC EDGAR ↗
Advertisement
DERM
Journey Medical Corp
Sell Maraoui Claude · Director, President & CEO · Open-market sale · filed May 5, 2025 ΔOwn −0.2%

Maraoui Claude sold $33.1K of DERM.

−$33.1K
4,834 sh @ $7
DERM
Journey Medical Corp
Sell Benesch Joseph · CFO · Open-market sale · filed May 5, 2025 ΔOwn −1.2%

Benesch Joseph sold $16.5K of DERM, trimming their stake 1%.

−$16.5K
2,409 sh @ $7
DERM
Journey Medical Corp
Sell Alloush Ramsey · COO · Open-market sale · filed May 5, 2025 ΔOwn −0.6%

Alloush Ramsey sold $19.5K of DERM, trimming their stake 1%.

−$19.5K
2,857 sh @ $7
DERM
Journey Medical Corp
Sell Maraoui Claude · Director, President & CEO · Open-market sale · filed Mar 11, 2025 ΔOwn −2.4%

Maraoui Claude sold $246.8K of DERM, trimming their stake 2%.

−$246.8K
49,271 sh @ $5
DERM
Journey Medical Corp
Sell Maraoui Claude · Director, President & CEO · Open-market sale · filed Mar 10, 2025 ΔOwn −0.7%

Maraoui Claude sold $74.7K of DERM, trimming their stake 1%.

−$74.7K
14,905 sh @ $5
DERM
Journey Medical Corp
Sell Maraoui Claude · Director, President & CEO · Open-market sale · filed Mar 10, 2025 ΔOwn −1.2%

Maraoui Claude sold $128.8K of DERM, trimming their stake 1%.

−$128.8K
25,551 sh @ $5
DERM
Journey Medical Corp
Sell Maraoui Claude · Director, President & CEO · Open-market sale · filed Mar 5, 2025 ΔOwn −0.9%

Maraoui Claude sold $93.1K of DERM, trimming their stake 1%.

−$93.1K
18,147 sh @ $5
DERM
Journey Medical Corp
Sell Maraoui Claude · Director, President & CEO · Open-market sale · filed Mar 5, 2025 ΔOwn −1.4%

Maraoui Claude sold $145.7K of DERM, trimming their stake 1%.

−$145.7K
28,901 sh @ $5
DERM
Journey Medical Corp
Sell Maraoui Claude · Director, President & CEO · Open-market sale · filed Mar 5, 2025 ΔOwn −1.1%

Maraoui Claude sold $122K of DERM, trimming their stake 1%.

−$122K
23,508 sh @ $5
Advertisement

About DERM insider activity

This page tracks every recent Form 4 filed for Journey Medical Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is DERM insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Journey Medical Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.